Quince Therapeutics (QNCX) Earnings Date & Reports

Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

QNCX is expected to report earnings to fall 90.82% to -112 cents per share on November 18

Quince Therapeutics QNCX Stock Earnings Reports

Q3'26

Est.

$-1.13

Q2'26

Missed

by $2.91

Q1'26

Beat

by $80.00

Q4'25

Missed

by $1.57

Q3'25

Missed

by $0.03

The last earnings report on August 14 showed earnings per share of -1231 cents, missing the estimate of -939 cents. With 2.75K shares outstanding, the current market capitalization sits at 34.51M.

View a ticker or compare two or three

QNCX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days